These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37321153)

  • 21. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].
    Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
    Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
    Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters.
    Xiao Y; Linghu H
    Cancer Control; 2023; 30():10732748231159778. PubMed ID: 36815671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
    Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
    Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the 2009 FIGO staging system really valuable for stage I endometrial cancer?
    Atalay F; Cetinkaya K; Bacinoglu A
    Eur J Gynaecol Oncol; 2013; 34(6):556-8. PubMed ID: 24601051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma.
    Shih KK; Yun E; Gardner GJ; Barakat RR; Chi DS; Leitao MM
    Gynecol Oncol; 2011 Sep; 122(3):608-11. PubMed ID: 21664663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.
    Lambrou NC; Gómez-Marín O; Mirhashemi R; Beach H; Salom E; Almeida-Parra Z; Peñalver M
    Gynecol Oncol; 2004 Jun; 93(3):653-8. PubMed ID: 15196860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy.
    Kong TW; Jo E; Son JH; Paek J; Chang SJ; Ryu HS
    J Obstet Gynaecol Res; 2021 Sep; 47(9):3322-3330. PubMed ID: 34196087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of prognosis in patients with endometrioid endometrial cancer staged IB in FIGO 1988 and 2009 classifications.
    Gottwald L; Moszynska-Zielińska M; Spych M; Korczynski J; Tylinski W; Szwalski J; Kubiak R; Pasz-Walczak G; Sobotkowski J; Suzin J; Piekarski J
    Arch Gynecol Obstet; 2012 Oct; 286(4):995-1000. PubMed ID: 22627994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery.
    Ueda Y; Enomoto T; Miyatake T; Egawa-Takata T; Ugaki H; Yoshino K; Fujita M; Kimura T
    Ann Surg Oncol; 2010 Apr; 17(4):1111-7. PubMed ID: 20058191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.
    Tajik P; van de Vrie R; Zafarmand MH; Coens C; Buist MR; Vergote I; Bossuyt PMM; Kenter GG
    Int J Gynecol Cancer; 2018 Mar; 28(3):453-458. PubMed ID: 29324537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system.
    Kato T; Watari H; Endo D; Mitamura T; Odagiri T; Konno Y; Hosaka M; Kobayashi N; Todo Y; Sudo S; Takeda M; Dong P; Kaneuchi M; Kudo M; Sakuragi N
    J Surg Oncol; 2012 Dec; 106(8):938-41. PubMed ID: 22740340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
    Lim H; Bang SH; Kim Y; Cho SH; Shin W; Kim SI; Kim TH; Suh DH; Lim MC; Kim JW
    BMC Cancer; 2022 Jun; 22(1):703. PubMed ID: 35761211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.